The mutation is thought to be significantly associated with ALS progression because it results in decreased expression of ZNF512B, followed by decreased TGF-β signaling finally resulting in neuronal degradation [50]. The gene discussed is ZNF512B; the disease is amyotrophic lateral sclerosis.